Metformin therapy in diabetes: the role of cardioprotection.
about
Adenosine monophosphate-activated protein kinase in diabetic nephropathyThe mitochondria in diabetic heart failure: from pathogenesis to therapeutic promiseThe Association between 25-Hydroxyvitamin D and Hemoglobin A1c Levels in Patients with Type 2 Diabetes and Stage 1-5 Chronic Kidney Disease.Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study.Tissue factor expression in obese type 2 diabetic subjects and its regulation by antidiabetic agents.Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity.Metformin is a novel suppressor for transforming growth factor (TGF)-β1AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular DiseaseTargeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction.Postconditioning with metformin attenuates apoptotic events in cardiomyoblasts associated with ischemic reperfusion injury.Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.Protective effects of desacyl ghrelin on diabetic cardiomyopathy.Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats.Liver enzyme trends in patients taking uninterrupted metformin before and after coronary surgeryDiabetic Cardiomyopathy: Distinct and Preventable Entity or Inevitable Consequence?
P2860
Q26745623-EC678C21-8210-4556-B2A5-9EEF9DB14924Q26829731-ABD217BD-AD2A-43D0-861B-255BE2B8F880Q34176759-67DA7966-E6C9-4293-9CFA-8901324B1AC9Q35155185-71D82337-2BD6-4E5F-9877-706EF247800FQ35227034-8C285480-68F4-46F9-8D9D-FA0F5246B069Q35736638-826515CB-DCB3-4DEF-98B2-6A4C5EB0CBADQ37044398-660EDD84-B242-4F01-885F-FBA84298398AQ37138635-D995F49F-2820-45FC-AC2F-E39EE7AFF8D8Q37686277-C18142E6-ACB4-4716-95E9-79F834A6A9B3Q38374396-10A02DAF-D2E8-49A4-87C6-E109A4F254DBQ41498937-01F8F082-D6E4-4E50-85D7-A402CFABE4DBQ48231806-0060138B-2672-4768-B88B-3C81F0F7F3CAQ51125944-0B7E1DD4-3ED1-4FA6-9551-ADDD18811F8BQ51793866-1BDF0B91-427B-4746-9CF8-8EDD399C6A3DQ52887129-AE79306A-2E97-4E0E-AC42-229F73D75195Q58804510-47E0C745-1E8B-462D-A89F-ECE19589C069Q59192076-6C6D3850-F155-403E-9A12-4340723E6A60
P2860
Metformin therapy in diabetes: the role of cardioprotection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metformin therapy in diabetes: the role of cardioprotection.
@en
type
label
Metformin therapy in diabetes: the role of cardioprotection.
@en
prefLabel
Metformin therapy in diabetes: the role of cardioprotection.
@en
P2093
P2860
P1476
Metformin therapy in diabetes: the role of cardioprotection.
@en
P2093
Gerard A Rongen
Niels P Riksen
Saloua El Messaoudi
P2860
P2888
P356
10.1007/S11883-013-0314-Z
P577
2013-04-01T00:00:00Z
P6179
1019345392